OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-12-31-accounts

Trustees’ Annual Report for the period

From 1 January 2024 To 31 December 2024

Charity name: Arrhythmogenic Cardiomyopathy Trust

Charity registration number: 1176790

Objectives and Activities

SORP reference
Summary of the purposes of
the charity as set out in its
governing document
Para 1.17 TO PROMOTE AND PROTECT GOOD
HEALTH FOR THE PUBLIC BENEFIT,
RELATING TO INHERITED HEART
CONDITIONS AND IN PARTICULAR
ARRYTHMOGENIC CARDIOMYOPATHY
BY FUNDING RESEARCH PROJECTS,
SUCH PROJECTS CAN BE
DIAGNOSTIC, CURATIVE,
THERAPEUTIC OR PALLIATIVE IN
NATURE AND TO ENSURE THE
PUBLICATION OF THE USEFUL
RESULTS OF SUCH RESEARCH.
Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.
Para 1.17 and
1.19
Further fundraising, with a view to funding
a second project in 2026.
Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit
Para 1.18 This guidance has been noted by the
trustees of the charity.

Achievements and Performance

SORP reference
Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.
Para 1.20
During the year, the charity has
successfully raised a further £7,055 to
support its objectives of funding medical
research projects focussed on
Arrhythmogenic Cardiomyopathy, a heart
muscle disease that affects young people.

Financial Review

Financial Review
Review of the charity’s
financial position at the end
of the period
Para 1.21 The charity had cash reserves of £35,023 at
year end. The charity holds only cash
deposits, with no debt.
Statement explaining the
policy for holding reserves
stating why they are held
Para 1.22 Reserves will be held on an ongoing basis
until a research project is successfully
funded.
Amount of reserves held Para 1.22 £35,023
Reasons for holding zero
reserves
Para 1.22 n/a
Details of fund materially in
deficit
Para 1.24 n/a
Explanation of any
uncertainties about the
charity continuing as a going
concern
Para 1.23 No concerns

Structure, Governance and Management

Description of charity’s

~~t~~
~~t~~
Type of governing document
(trust deed, royal charter)

Para 1.25
CIO governing document
How is the charity
constituted?
(e.g unincorporated
association, CIO)
Para 1.25 CIO
Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
Para 1.25 Trustees appointed by resolution of existing
trustees
~~trustees~~

Reference and Administrative details

Charity name Arrhythmogenic Cardiomyopathy Trust
Other name the charity uses ACT
Registered charity number 1176790
Charity’s principal address 97 Rosebank, Holyport Road, London SW6 6LJ

Names of the charity trustees who manage the charity

Trustee name Office (if any) Dates acted if not for
whole year
Name of person (or body)
entitled to appoint trustee
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
James Minch Trustee ~~(if any)~~
Kate Minch Trustee
Rachel Bailey Trustee

Corporate trustees – names of the directors at the date the report was approved

Director name

Name of trustees holding title to property belonging to the charity

Trustee name Dates acted rf not for whole year

Funds held as custodian trustees on behalf of others

Description of the assets
held in this capacity
n/a
Name and objects of the
charity on whose behalf the
assets are held and how this
falls within the custodian
charity’s objects
n/a
Details of arrangements for
safe custody and
segregation of such assets
from the charity’s own assets
n/a

Exemptions from disclosure

Reason for non-disclosure of key personnel details

Other optional information

----- Start of picture text -----
Charity Name No (if any)
Arrhythmogenic Cardiomyopathy Trust 1176790
Receipts and payments accounts CC16a
For the period Period start date Period end date
To
from 01-Jan-24 31-Dec-24
Section A Receipts and payments
Unrestricted Restricted Endowment
Total funds Last year
funds funds funds
to the nearest £ to the nearest £ to the nearest £ to the nearest £ to the nearest £
A1 Receipts
Donations 7,055 - - 7,055 -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
Sub total (Gross income for
AR) [ 7,055 ] - - 7,055 -
A2 Asset and investment sales,
(see table).
- - - -
- - - - -
Sub total - - - - -
Total receipts 7,055 - - 7,055 -
A3 Payments
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
Sub total [ - ] - - - -
A4 Asset and investment
purchases, (see table)
- - - -
- - - -
Sub total [ - ] - - - -
Total payments - - - - -
Net of receipts/(payments) 7,055 - - 7,055 -
A5 Transfers between funds - - - - -
A6 Cash funds last year end - - - - -
Cash funds this year end 7,055 - - 7,055 -
----- End of picture text -----

CCXX R1 accounts (SS)

31/10/2025

1

Section B Statement of assets and liabilities at the end of the period

Categories
Signed by one or two trustees on
behalf of all the trustees
B5 Liabilities
B3 Investment assets
B2 Other monetary assets
B4 Assets retained for the
charity’s own use
B1 Cash funds
Details
Details
Total cash funds
(agree balances with receipts and payments
account(s))
Cash at bank
Details
Details
Details
Signature
Unrestricted
funds
Restricted
funds
to nearest £
to nearest £
35,023
-
-
-
-
-
35,023
-
Agreement Error
OK
Unrestricted
funds
Restricted
funds
to nearest £
to nearest £
-
-
-
-
-
-
-
-
-
-
-
-
Fund to which
asset belongs
Cost (optional)
-
-
-
-
-
Fund to which
asset belongs
Cost (optional)
-
-
-
-
-
-
-
-
-
Fund to which
liability relates
Amount due
(optional)
-
-
-
-
-
Print Name
Endowment
funds
to nearest £
-
-
-
-
OK
Endowment
funds
to nearest £
-
-
-
-
-
-
Current value
(optional)
-
-
-
-
-
Current value
(optional)
-
-
-
-
-
-
-
-
-
When due
(optional)
Date of
approval

CCXX R2 accounts (SS)

31/10/2025

2